Causes of Hypoglycemia During Dialysis
Hypoglycemia during dialysis is primarily caused by decreased gluconeogenesis, impaired insulin clearance, and increased erythrocyte glucose uptake during the dialysis procedure. 1
Multiple Mechanisms of Dialysis-Induced Hypoglycemia
Patients undergoing dialysis, especially those with diabetes, are at high risk for hypoglycemia due to several physiological changes that occur during the procedure:
Primary Mechanisms
Decreased renal gluconeogenesis 1
- The kidney is a major site of glucose production through gluconeogenesis
- Advanced kidney disease significantly impairs this process
Altered insulin metabolism 1
- Impaired insulin clearance by the kidney
- Reduced insulin degradation due to uremia
- Decreased insulin requirements as kidney function declines
Dialysis-specific factors 1, 2
- Increased erythrocyte glucose uptake during hemodialysis
- Glucose loss to the dialysate, especially with glucose-free dialysate
- Rapid fluid shifts altering glucose distribution
Additional Contributing Factors
Impaired counterregulatory hormone responses (cortisol, growth hormone) 1
- Inadequate nutrition before or during dialysis
- Fasting or reduced food intake around dialysis sessions
Medication effects 4
- Prolonged action of insulin and oral hypoglycemic agents
- Variable exposure to antihyperglycemic medications due to dialysis
Clinical Evidence and Prevalence
Research shows that hypoglycemia during dialysis is common and often asymptomatic. In a study using continuous glucose monitoring, 21% of diabetic patients experienced dialysis-related hypoglycemia (glucose <70 mg/dL) despite using dialysate containing 100-150 mg/dL glucose 2. All these hypoglycemic episodes were asymptomatic, highlighting the importance of monitoring.
Another study demonstrated that asymptomatic hypoglycemia was frequent during hemodialysis when glucose-free dialysis solution was used 5. Adding glucose (90 mg/dL) to the dialysate significantly reduced hypoglycemic episodes.
"Burn-out Diabetes" Phenomenon
An interesting phenomenon called "burn-out diabetes" occurs in approximately 15-30% of patients with end-stage kidney disease (GFR <20 mL/min/1.73 m²) and type 2 diabetes 1. These patients, previously requiring insulin or other antihyperglycemic agents, need less or no medications for glycemic control as kidney disease advances to end-stage.
Dialysate Glucose Concentration
The glucose concentration in the dialysate significantly impacts blood glucose levels during dialysis:
- Glucose-free dialysate increases hypoglycemia risk 5, 6
- Dialysate with 55 mg/dL glucose does not adequately prevent hypoglycemia 6
- Dialysate with 90 mg/dL glucose significantly reduces hypoglycemic episodes 5
Clinical Implications
Hypoglycemia during dialysis carries significant risks:
- Associated with higher mortality after dialysis initiation 3
- Can contribute to cognitive impairment and memory loss 3
- Increases risk of recurrent hypoglycemia 3
Prevention Strategies
To prevent dialysis-induced hypoglycemia:
- Use dialysate containing adequate glucose (90 mg/dL or higher) 5, 6
- Adjust insulin and oral hypoglycemic medications before dialysis 4
- Consider continuous glucose monitoring to detect asymptomatic hypoglycemia 1, 2
- Ensure adequate nutrition before and after dialysis sessions 1, 3
- Monitor for hypoglycemia symptoms, recognizing that many episodes may be asymptomatic 2
Hypoglycemia during dialysis represents a significant clinical challenge that requires careful monitoring and management to prevent adverse outcomes and improve patient quality of life.